Market Tracker

10/24 6:05pm ET

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.5299
Data as of Oct 24
 -0.0075 / -1.40%
Today’s Change
0.40
Today|||52-Week Range
1.10
+14.60%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.54
Today’s open0.54
Day’s range0.52 - 0.54
Volume263,415
Average volume (3 months)716,849
Market cap$66.8M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+15.15%
Earnings growth (this year)+8.93%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.14

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc-0.08-1.52%
ADXSAdvaxis Inc+0.25+8.12%
EPRSEPIRUS Biopharmaceut...-0.08-1.57%
COCPCocrystal Pharma Inc+0.05+10.42%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$21.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
President, Chief Operating Officer &
Secretary
Patrick L. Keran
Corporate headquarters
San Diego, California

Forecasts